J Electrocardiol 1986 Jul;19(3):213-23.
Non-invasive detection of coronary artery disease by body surface
electrocardiographic mapping after dipyridamole infusion.
Ikeda K, Kawashima S, Kubota I, Igarashi A, Yamaki M, Yasumura S, Tsuiki K, Yasui S,
NIL
Jpn Heart J 1986 Jul;27(4):489-500.
Comparison of the electrocardiographic changes induced by dipyridamole
infusion and treadmill exercise in patients with coronary artery disease.
Kawashima S, Kubota I, Ikeda K, Tsuiki K, Yasui S,
NIL
J Electrocardiol 1987 Apr;20(2):114-20.
Using body surface mapping to detect vulnerability to ventricular
arrhythmias in patients with coronary artery disease.
Yasumura S, Kubota I, Ikeda K, Tsuiki K, Yasui S,
NIL
Jpn Heart J 1991 Nov;32(6):751-8.
Relation between the incidence of arrhythmias and ischemic ST-segment
depression during dipyridamole electrocardiography test in patients with
coronary artery disease.
Shibata T, Kubota I, Ikeda K, Yamaki M, Hanashima K, Tsuiki K, Yasui S,
First Department of Internal Medicine, Yamagata University School of
Medicine, Japan.
Intern Med 1992 Feb;31(2):147-53.
Dipyridamole electrocardiography test for the detection of severe coronary
artery stenoses.
Ikeda K, Kubota I, Yamaki M, Kato N, Honma K, Hosoya Y, Tsuiki K, Yasui S,
First Department of Internal Medicine, Yamagata University School of
Medicine, Japan.
Jpn Circ J 1992 Mar;56(3):223-34.
Dipyridamole electrocardiography test for the assessment of the severity
of coronary artery disease.
Ikeda K, Kubota I, Yamaki M, Kato N, Hosoya Y, Tomoike H, Yasui S,
First Department of Internal Medicine, Yamagata University School of
Medicine, Japan.
Eur J Nucl Med 1997 Feb;24(2):160-9.
ECG-manifest and ECG-silent dipyridamole technetium-99m sestamibi SPET
perfusion defects in patients with ischaemic heart disease.
Galli M, Marcassa C, Bosimini E, Zoccarato O, Comazzi F, Giannuzzi P,
Cardiology Division, "Salvatore Maugeri" Foundation IRCCS, Veruno (No),
Italy.
J Electrocardiol 2002 Jul;35(3):181-91.
Dipyridamole body surface potential mapping: noninvasive differentiation
of syndrome X from coronary artery disease.
Boudik F, Anger Z, Aschermann M, Vojacek J, Tomeckova M,
second Department of Internal Medicine, Charles University Hospital,
Prague, Czech Republic. fboud@lfl.cuni.cz